Skip to main content

Table 1 Summary characteristics of patients with isolated orbital Mucormycosis

From: Orbital mucormycosis in immunocompetent children; review of risk factors, diagnosis, and treatment approach

 

Yeara

Age

Sex

The onset

of symptoms PTA

Clinical features

Ophthal. exam

Concurrent sinusitis

Diagnostic approach 1

Predisposing factors

Treatment strategy

Treatment duration

Surgical debridement

Follow-up and outcome

Our case series

 1

2017

7/M

F

6/W

Dacryocystitis + Periorbital cellulitis

Left conjunctival injection and firm fixed mass on the inferomedial aspect of the left canthus

Yes

Pathology, fungal culture, KOH, molecular confirmation

Gardening

DAmB (1.5 mg/kg/day)/ LAmB (5 mg/kg/day)

8/W

Orbitotomy+ debulking (three times)

3/Y, Complete cure

 2

2017

9/M

F

1/W

Dacryocystitis

+ Periorbital cellulitis

Peri-orbital edema, and erythema extended to the superior side of the right medial canthus

Yes

Pathology, fungal culture, KOH, molecular confirmation

Trauma (nasolacrimal duct probing)

DAmB (1.5 mg/kg/day)/ LAmB (5 mg/kg/day)

9/W

Orbitotomy+ debulking (two times)

3/Y, Complete cure

 3

2018

18/M

M

4/W

Orbital cellulitis

Right eye proptosis, purulent discharge, and peri-orbital swelling and redness

Yes

Pathology, fungal culture, KOH, molecular confirmation

Not identified

LAmB (5 mg/kg/day)/ PSC 2 (200 mg/q 6 h)

17/W

Orbitotomy+ debulking (five times)

2/Y, Complete cure

 4

2019

10/M

M

1/W

Periorbital cellulitis

Right peri-orbital erythema and swelling

No

Pathology, fungal culture, KOH, molecular confirmation

Not identified

DAmB (1.5 mg/kg/day)/ LAmB (5 mg/kg/day)/PSC (200 mg/q 6 h)

12/W

Orbitotomy+ debulking

9/M, Complete cure

 5

2019

3/Y

M

6/W

Periorbital cellulitis

Left sub-orbital swelling

No

Pathology, fungal culture, KOH, molecular confirmation

Frequent exposure to corn and fodder storage and hay

DAmB (1.5 mg/kg/day)/ LAmB (5 mg/kg/day)/ PSC (200 mg/q 6 h)

12/W

Orbitotomy+ debulking (four times)

5/M, Complete cure

Previous case reports

 6

2012 [8]

2/Y

M

18/days

Periorbital cellulitis

NA

Pathology, fungal culture, KOH

Not reported

DAmB, ICZ

6/M

Anterior orbitotomy and debulking

2/Y, Complete cure

 7

1951 [9]

10/Y

M

NA

Exudative retinitis

NA

Pathology

Coat’s disease

NA

NA

Enucleation

NA

 8

2009 [10]

71

M

1/day

Orbital cellulitis

NA

Pathology

Diabetes mellitus, non-Hodgkin lymphoma of diffuse large B-cell (DLCBL)

LAmB, PSC

About 40/days

Extensive surgical debridement

Death

 9

2014 [11]

13

M

3/W

Periorbital cellulitis

NA

Pathology

Gardening, immunocompetent, concurrent corticosteroid therapy for approximately 1/M

DAmB

26/days

Orbital exenteration

Cure with morbidity

  1. Abbreviations: M male, F female, PTA prior to admission, Ophthal. exam ophthalmic examination, DAmB deoxycholate amphotericin B, LAmB liposomal amphotericin B, PSC posaconazole, ICZ Itraconazole;
  2. aPresentation year [reference]
  3. 1Including standard diagnostic tests (presence of fungal broad, non-septate hyphae in pathologic examination or growth of Mucormycosis on sabouraud dextrose agar (SDA) and indirect mycologic test (fungal PCR) in tissue biopsy
  4. 2Noxafil 40 mg/ml oral suspension; Manufacture by MSD company